FDG-PET may aid treatment decisions for prostate cancer

07/2/2013 | Renal and Urology News

A study presented at a urological meeting found that in patients with prostate cancer, FDG uptake by the prostate as seen on PET scans may be useful for determining whether to treat with radical prostatectomy. "Since there is a high failure rate with prostatectomy, the presence or absence of FDG uptake can help you decide whether to still do a radical prostatectomy in a morbid patient or just reorient the patient to radiation therapy or androgen deprivation therapy," said lead researcher Dr. Frederic Pouliot from Laval University in Quebec. The team compared results from FDG-PET imaging with those from surgery.

View Full Article in:

Renal and Urology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ